The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care

A panelist discusses how digital patient engagement tools and collaboration with advocacy groups can enhance treatment adherence and care coordination while providing vital support and resources for individuals managing Lambert-Eaton myasthenic syndrome (LEMS).

EP: 1.LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection

EP: 2.Strategies to Alleviate the Clinical and Economic Burden of LEMS

EP: 3.The Clinical and Economic Impact of LEMS in SCLC Care

EP: 4.Using Technology for Early Detection of LEMS

EP: 5.Team- and System-Based Approaches to Managing LEMS and Ensuring Access

Now Viewing

EP: 6.The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care

Video content above is prompted by the following:

• How can patient engagement tools and technology improve adherence and patient satisfaction in LEMS treatment?
• What role do patient advocacy groups play in supporting care coordination and resource allocation for LEMS patients?

Related Videos

Related Content

Advertisement

January 7th 2025

Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations

Brooke McCormick

Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

January 6th 2025

MRD Status Prior to Allo-HSCT Shows Strong Prognostic Value in AML, MDS

Kimberly Rath, PharmD

A study demonstrated that pre-transplant measurable residual disease (MRD) status is a strong prognostic factor for overall survival, disease-free survival, and relapse risk in patients with AML and MDS undergoing allogeneic stem cell transplantation.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

January 6th 2025

Male Patients With Eosinophilic Esophagitis Face Higher Complication Rates

Brooke McCormick

Compared with female patients, male patients with eosinophilic esophagitis have higher rates of complications, including esophageal obstruction, food impaction, and rupture, highlighting potential gender differences in disease severity.

January 4th 2025

Efgartigimod Leads to Sustained Myasthenia Gravis Improvement

Jared Kaltwasser

Patients with generalized myasthenia gravis experienced durable improvements across measures of efficacy and regardless of the time since they were diagnosed.

Related Content

Advertisement

January 7th 2025

Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations

Brooke McCormick

Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

January 6th 2025

MRD Status Prior to Allo-HSCT Shows Strong Prognostic Value in AML, MDS

Kimberly Rath, PharmD

A study demonstrated that pre-transplant measurable residual disease (MRD) status is a strong prognostic factor for overall survival, disease-free survival, and relapse risk in patients with AML and MDS undergoing allogeneic stem cell transplantation.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

January 6th 2025

Male Patients With Eosinophilic Esophagitis Face Higher Complication Rates

Brooke McCormick

Compared with female patients, male patients with eosinophilic esophagitis have higher rates of complications, including esophageal obstruction, food impaction, and rupture, highlighting potential gender differences in disease severity.

January 4th 2025

Efgartigimod Leads to Sustained Myasthenia Gravis Improvement

Jared Kaltwasser

Patients with generalized myasthenia gravis experienced durable improvements across measures of efficacy and regardless of the time since they were diagnosed.